HHS MSJ SUPPORTS PREVIOUS ADMINISTRATION’S POSITION DENYING PHARMACEUTICAL MANUFACTURERS THE UNILATERAL RIGHT TO IMPLEMENT REBATE PROGRAMS FOR 340B DRUGS
The Department of Health and Human Services has filed a Cross-Motion for Summary Judgment supporting the previous administration’s position that pharmaceutical manufacturers do not have the unilateral right to implement rebate programs for 340B drugs. The MSJ brief argues that HHS was well within its statutory authority to prevent the manufacturers from unilaterally implementing the […]